Paul McBarron
2017
In 2017, Paul McBarron earned a total compensation of $420.1K as Executive Vice President, Finance, Chief Operating Officer, Chief Financial Officer, Secretary at Cyclacel Pharmaceuticals, a 18% increase compared to previous year.
Compensation breakdown
| Bonus | $98,621 |
|---|---|
| Option Awards | $18,722 |
| Salary | $281,772 |
| Other | $20,970 |
| Total | $420,085 |
McBarron received $281.8K in salary, accounting for 67% of the total pay in 2017.
McBarron also received $98.6K in bonus, $18.7K in option awards and $21K in other compensation.
Rankings
In 2017, Paul McBarron's compensation ranked 12,461st out of 14,666 executives tracked by ExecPay. In other words, McBarron earned more than 15.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 12,461 out of 14,666 | 15th |
Division Manufacturing | 4,904 out of 5,772 | 15th |
Major group Chemicals And Allied Products | 1,797 out of 2,075 | 13th |
Industry group Drugs | 1,495 out of 1,731 | 14th |
Industry Pharmaceutical Preparations | 1,157 out of 1,333 | 13th |
Source: SEC filing on April 12, 2018.
McBarron's colleagues
We found two more compensation records of executives who worked with Paul McBarron at Cyclacel Pharmaceuticals in 2017.
News
Cyclacel Pharmaceuticals CEO Spiro Rombotis' 2023 pay slips 13% to $661K
May 7, 2024
Cyclacel Pharmaceuticals CEO Spiro Rombotis' 2022 pay falls 43% to $764K
April 28, 2023
Cyclacel Pharmaceuticals CEO Spiro Rombotis' 2021 pay slips 5% to $1.3M
April 26, 2022
Cyclacel Pharmaceuticals CEO Spiro Rombotis' 2020 pay jumps 39% to $1.4M
April 29, 2021
Cyclacel Pharmaceuticals CEO Spiro Rombotis' 2019 pay jumps 35% to $1M
May 12, 2020